Keywords
Last Name
Institution

Therese K Killeen

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
539N
67 President St.
Phone843-792-5232
Fax843-792-7353
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Killeen's general research interests are in the area of effective treatment approaches for substance use disorders (SUD) and comorbidity, with a particular expertise in PTSD and SUD comorbidity. She has lead several large NIDA Clinical Trial Network studies exploring psychosocial therapies in the treatment of substance use and comorbid disorders. She is an expert in motivational interviewing, cognitive behavior and contingency management therapies, and more recently she is involved in research exploring the effectiveness of using mindfulness based relapse prevention in improving substance use outcomes. In her role as dissemination specialist over the past 15 years, she has worked with front line community treatment programs and clinicians to adopt evidence based treatments. She has mentored numerous clinicians both within MUSC and in community practice using evidence based supervision.

    Collapse keywords
    Stress Disorders, Complementary Medicine, Substance Use, addiction treatment, comorbidity, PTSD, dissemination, supervision

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Lancaster CL, Gros DF, Mullarkey MC, Badour CL, Killeen TK, Brady KT, Back SE. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behav Cogn Psychother. 2019 Apr 23; 1-16. PMID: 31010449.
      View in: PubMed
    2. Jeffirs SM, Jarnecke AM, Flanagan JC, Killeen TK, Laffey TF, Back SE. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 Jun 01; 199:70-75. PMID: 31009834.
      View in: PubMed
    3. Szafranski DD, Gros DF, Acierno R, Brady KT, Killeen TK, Back SE. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters. Clin Psychol Psychother. 2019 Mar; 26(2):218-226. PMID: 30419153.
      View in: PubMed
    4. Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 Mar; 90:369-377. PMID: 30529244.
      View in: PubMed
    5. Jarnecke AM, Allan NP, Badour CL, Flanagan JC, Killeen TK, Back SE. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 Mar; 90:35-39. PMID: 30355535.
      View in: PubMed
    6. Hu L, Matthews A, Shmueli-Blumberg D, Killeen TK, Tai B, VanVeldhuisen P. Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials. Drug Alcohol Depend. 2018 09 01; 190:255-262. PMID: 30077926.
      View in: PubMed
    7. Spratt ES, Papa CE, Mueller M, Patel S, Killeen T, Maher E, Drayton C, Dixon TC, Fowler SL, Treiber F. Using Technology to Improve Adherence to HIV Medications in Transitional Age Youth: Research Reviewed, Methods Tried, Lessons Learned. J Gen Med (Dover). 2017; 1(1). PMID: 30345429.
      View in: PubMed
    8. Vrana C, Killeen T, Brant V, Mastrogiovanni J, Baker NL. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. Contemp Clin Trials. 2017 10; 61:108-114. PMID: 28765006.
      View in: PubMed
    9. Flanagan JC, Fischer MS, Badour CL, Ornan G, Killeen TK, Back SE. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218. PMID: 28541802.
      View in: PubMed
    10. Ruglass LM, Lopez-Castro T, Papini S, Killeen T, Back SE, Hien DA. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161. PMID: 28490022.
      View in: PubMed
    11. Szafranski DD, Snead A, Allan NP, Gros DF, Killeen T, Flanagan J, Pericot-Valverde I, Back SE. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35. PMID: 28460246.
      View in: PubMed
    12. Mills AC, Badour CL, Korte KJ, Killeen TK, Henschel AV, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length. J Trauma Stress. 2017 04; 30(2):166-172. PMID: 28329434.
      View in: PubMed
    13. Persson A, Back SE, Killeen TK, Brady KT, Schwandt ML, Heilig M, Magnusson Å. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women. J Addict Med. 2017 Mar/Apr; 11(2):119-125. PMID: 28079572.
      View in: PubMed
    14. Badour CL, Flanagan JC, Gros DF, Killeen T, Pericot-Valverde I, Korte KJ, Allan NP, Back SE. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281. PMID: 28221062.
      View in: PubMed
    15. Sherman BJ, McRae-Clark AL, Baker NL, Sonne SC, Killeen TK, Cloud K, Gray KM. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144. PMID: 28152236.
      View in: PubMed
    16. Jaconis M, Santa Ana EJ, Killeen TK, Badour CL, Back SE. Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran. Am J Addict. 2017 Mar; 26(2):112-114. PMID: 28118514.
      View in: PubMed
    17. Korte KJ, Bountress KE, Tomko RL, Killeen T, Moran-Santa Maria M, Back SE. Integrated Treatment of PTSD and Substance Use Disorders: The Mediating Role of PTSD Improvement in the Reduction of Depression. J Clin Med. 2017 Jan 13; 6(1). PMID: 28098747.
      View in: PubMed
    18. Merghati-Khoei ES, Rezaei Z, Shojaei-Zadeh D, Azadi NA, Rimaz S, Bayat A, Moayedi-Nia S, Omati S, Salimi F, Korte J, Killeen T, Mohraz M. Sexual Risk Behaviors and Condom Use Barriers in Iranian Men with Substance Use Disorders. Addict Health. 2017 Jan; 9(1):40-47. PMID: 29026502.
      View in: PubMed
    19. Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent Treatment of Substance Use and PTSD. Curr Psychiatry Rep. 2016 08; 18(8):70. PMID: 27278509.
      View in: PubMed
    20. Hatch-Maillette M, Wells EA, Doyle SR, Brigham GS, Daley D, DiCenzo J, Donovan D, Garrett S, Horigian VE, Jenkins L, Killeen T, Owens M, Perl HI. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders. J Subst Abuse Treat. 2016 09; 68:74-82. PMID: 27431050.
      View in: PubMed
    21. Adams ZW, McCauley JL, Back SE, Flanagan JC, Hanson RF, Killeen TK, Danielson CK. Clinician Perspectives on Treating Adolescents with Co-occurring Post-Traumatic Stress Disorder, Substance Use, and Other Problems. J Child Adolesc Subst Abuse. 2016; 25(6):575-583. PMID: 27840568.
      View in: PubMed
    22. Marriott BP, Hibbeln JR, Killeen TK, Magruder KM, Holes-Lewis K, Tolliver BK, Turner TH. Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide. Contemp Clin Trials. 2016 Mar; 47:325-33. PMID: 26855120.
      View in: PubMed
    23. McRae-Clark AL, Baker NL, Gray KM, Killeen T, Hartwell KJ, Simonian SJ. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75. PMID: 26685701.
      View in: PubMed
    24. Wu LT, Brady KT, Spratt SE, Dunham AA, Heidenfelder B, Batch BC, Lindblad R, VanVeldhuisen P, Rusincovitch SA, Killeen TK, Ghitza UE. Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study. Contemp Clin Trials. 2016 Jan; 46:30-38. PMID: 26563446.
      View in: PubMed
    25. Killeen T, Brewerton TD, Campbell A, Cohen LR, Hien DA. Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders. Am J Drug Alcohol Abuse. 2015; 41(6):547-52. PMID: 26366716.
      View in: PubMed
    26. McRae-Clark AL, Baker NL, Gray KM, Killeen TK, Wagner AM, Brady KT, DeVane CL, Norton J. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37. PMID: 26386827.
      View in: PubMed
    27. Lozano BE, Gros DF, Killeen T, Jaconis M, Beylotte FM, Boyd S, Back SE. To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD. Am J Addict. 2015 Oct; 24(7):578-81. PMID: 26300219.
      View in: PubMed
    28. Jobe-Shields L, Flanagan JC, Killeen T, Back SE. Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23. PMID: 26132535.
      View in: PubMed
    29. Killeen TK, Back SE, Brady KT. Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug Alcohol Rev. 2015 May; 34(3):234-41. PMID: 25737377.
      View in: PubMed
    30. Chartier KG, Sanchez K, Killeen TK, Burrow A, Carmody T, Greer TL, Trivedi MH. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. Am J Addict. 2015 Jun; 24(4):336-40. PMID: 25694201.
      View in: PubMed
    31. Flanagan JC, Teer A, Beylotte FM, Killeen TK, Back SE. Correlates of Recent and Lifetime Aggression among Veterans with Co-Occurring PTSD and Substance Use Disorders. Ment Health Subst Use. 2014; 7(4):315-328. PMID: 25419233.
      View in: PubMed
    32. Merghati-Khoei E, Sheikhan F, Shamsalizadeh N, Haghani H, Yousofnia Pasha YR, Killeen T. Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study. J Sex Marital Ther. 2014; 40(6):552-60. PMID: 24308863.
      View in: PubMed
    33. Wu LT, Brady KT, Mannelli P, Killeen TK. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res. 2014 Mar; 50:26-35. PMID: 24342767.
      View in: PubMed
    34. Back SE, Killeen TK, Teer AP, Hartwell EE, Federline A, Beylotte F, Cox E. Substance use disorders and PTSD: an exploratory study of treatment preferences among military veterans. Addict Behav. 2014 Feb; 39(2):369-73. PMID: 24199930.
      View in: PubMed
    35. Brady KT, Haynes LF, Hartwell KJ, Killeen TK. Substance use disorders and anxiety: a treatment challenge for social workers. Soc Work Public Health. 2013; 28(3-4):407-23. PMID: 23731428.
      View in: PubMed
    36. McCauley JL, Killeen T, Gros DF, Brady KT, Back SE. Posttraumatic Stress Disorder and Co-Occurring Substance Use Disorders: Advances in Assessment and Treatment. Clin Psychol (New York). 2012 Sep 01; 19(3). PMID: 24179316.
      View in: PubMed
    37. Back SE, Killeen T, Foa EB, Santa Ana EJ, Gros DF, Brady KT. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. Am J Psychiatry. 2012 Jul; 169(7):688-91. PMID: 22760188.
      View in: PubMed
    38. Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR, Floyd AS, Knox PC, Botero C, Kelly TM, Killeen TK, Hayes C, Kau'i Baumhofer N, Kau'ibaumhofer N, Seamans C, Zammarelli L. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan; 44(1):103-14. PMID: 22657748.
      View in: PubMed
    39. Ruglass LM, Miele GM, Hien DA, Campbell AN, Hu MC, Caldeira N, Jiang H, Litt L, Killeen T, Hatch-Maillette M, Najavits L, Brown C, Robinson JA, Brigham GS, Nunes EV. Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Subst Use Misuse. 2012 May; 47(6):695-707. PMID: 22475068.
      View in: PubMed
    40. Killeen TK, McRae-Clark AL, Waldrop AE, Upadhyaya H, Brady KT. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs. 2012 Feb; 25(1):33-41. PMID: 22299805.
      View in: PubMed
    41. Killeen TK, Back SE, Brady KT. The Use of Exposure-Based Treatment Among Individuals With PTSD and Co-occurring Substance Use Disorders: Clinical Considerations. J Dual Diagn. 2011 Oct 01; 7(4):194-206. PMID: 23662094.
      View in: PubMed
    42. Greenfield SF, Rosa C, Putnins SI, Green CA, Brooks AJ, Calsyn DA, Cohen LR, Erickson S, Gordon SM, Haynes L, Killeen T, Miele G, Tross S, Winhusen T. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):301-12. PMID: 21854272.
      View in: PubMed
    43. Korte JE, Magruder KM, Chiuzan CC, Logan SL, Killeen T, Bandyopadhyay D, Brady KT. Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):358-66. PMID: 21854278.
      View in: PubMed
    44. Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64. PMID: 21802222.
      View in: PubMed
    45. Killeen TK, Greenfield SF, Bride BE, Cohen L, Gordon SM, Roman PM. Assessment and treatment of co-occurring eating disorders in privately funded addiction treatment programs. Am J Addict. 2011 May-Jun; 20(3):205-11. PMID: 21477048.
      View in: PubMed
    46. McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, White KG, Brady KT. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9. PMID: 20958842.
      View in: PubMed
    47. Hien DA, Campbell AN, Ruglass LM, Hu MC, Killeen T. The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study. Drug Alcohol Depend. 2010 Sep 01; 111(1-2):114-9. PMID: 20537811.
      View in: PubMed
    48. Cohen LR, Greenfield SF, Gordon S, Killeen T, Jiang H, Zhang Y, Hien D. Survey of eating disorder symptoms among women in treatment for substance abuse. Am J Addict. 2010 May-Jun; 19(3):245-51. PMID: 20525031.
      View in: PubMed
    49. McRae-Clark AL, Carter RE, Killeen TK, Carpenter MJ, Wahlquist AE, Simpson SA, Brady KT. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8. PMID: 19699593.
      View in: PubMed
    50. Hien DA, Wells EA, Jiang H, Suarez-Morales L, Campbell AN, Cohen LR, Miele GM, Killeen T, Brigham GS, Zhang Y, Hansen C, Hodgkins C, Hatch-Maillette M, Brown C, Kulaga A, Kristman-Valente A, Chu M, Sage R, Robinson JA, Liu D, Nunes EV. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug; 77(4):607-19. PMID: 19634955.
      View in: PubMed
    51. Hien DA, Campbell AN, Killeen T, Hu MC, Hansen C, Jiang H, Hatch-Maillette M, Miele GM, Cohen LR, Gan W, Resko SM, DiBono M, Wells EA, Nunes EV. The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav. 2010 Apr; 14(2):421-30. PMID: 19452271.
      View in: PubMed
    52. Gordon SM, Johnson JA, Greenfield SF, Cohen L, Killeen T, Roman PM. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008 Sep; 59(9):1056-9. PMID: 18757602.
      View in: PubMed
    53. Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008 Apr; 69(4):520-5. PMID: 18278987.
      View in: PubMed
    54. Killeen T, Hien D, Campbell A, Brown C, Hansen C, Jiang H, Kristman-Valente A, Neuenfeldt C, Rocz-de la Luz N, Sampson R, Suarez-Morales L, Wells E, Brigham G, Nunes E. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat. 2008 Oct; 35(3):304-11. PMID: 18294804.
      View in: PubMed
    55. Meier U, Ahmadi S, Killeen T, Al-Zain FT, Lemcke J. Long-term outcomes following decompressive craniectomy for severe head injury. Acta Neurochir Suppl. 2008; 102:29-31. PMID: 19388283.
      View in: PubMed
    56. Stitzer ML, Petry N, Peirce J, Kirby K, Killeen T, Roll J, Hamilton J, Stabile PQ, Sterling R, Brown C, Kolodner K, Li R. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol. 2007 Oct; 75(5):805-11. PMID: 17907862.
      View in: PubMed
    57. Killeen T, Carter R, Copersino M, Petry N, Stitzer M. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories. Am J Drug Alcohol Abuse. 2007; 33(1):129-37. PMID: 17366253.
      View in: PubMed
    58. Killeen TK. Long acting injectable naltrexone is effective and safe for treating alcohol dependence. Evid Based Ment Health. 2005 Nov; 8(4):100. PMID: 16246876.
      View in: PubMed
    59. Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, Macdonald M, Liebert M, Rader L, Burns R, DiMaria J, Copersino M, Stabile PQ, Kolodner K, Li R. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005 Oct; 62(10):1148-56. PMID: 16203960.
      View in: PubMed
    60. Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7. PMID: 15547458.
      View in: PubMed
    61. Killeen TK, Brady KT, Gold PB, Tyson C, Simpson KN. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend. 2004 Feb 07; 73(2):141-7. PMID: 14725953.
      View in: PubMed
    62. McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6. PMID: 15129422.
      View in: PubMed
    63. Back SE, Sonne SC, Killeen T, Dansky BS, Brady KT. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89. PMID: 12731687.
      View in: PubMed
    64. Killeen TK, Haight B, Brady K, Herman J, Michel Y, Stuart G, Young S. The effect of auricular acupuncture on psychophysiological measures of cocaine craving. Issues Ment Health Nurs. 2002 Jul-Aug; 23(5):445-59. PMID: 12079598.
      View in: PubMed
    65. Killeen T, Brady KT. Parental stress and child behavioral outcomes following substance abuse residential treatment. Follow-up at 6 and 12 months. J Subst Abuse Treat. 2000 Jul; 19(1):23-9. PMID: 10867297.
      View in: PubMed
    66. Killeen TK, Brady KT. Skin conductance hypo-responding in recently abstinent cocaine dependent inpatients. Am J Addict. 2000; 9(2):154-62. PMID: 10934577.
      View in: PubMed
    67. Brady KT, Killeen TK, Brewerton T, Lucerini S. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000; 61 Suppl 7:22-32. PMID: 10795606.
      View in: PubMed
    68. Dansky BS, Brady KT, Saladin ME, Killeen T, Becker S, Roitzsch J. Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse. 1996 Feb; 22(1):75-93. PMID: 8651146.
      View in: PubMed
    69. Killeen TK, Brady KT, Thevos A. Addiction severity, psychopathology and treatment compliance in cocaine-dependent mothers. J Addict Dis. 1995; 14(1):75-84. PMID: 7632749.
      View in: PubMed
    70. Brady KT, Killeen T, Jarrell P. Depression in alcoholic schizophrenic patients. Am J Psychiatry. 1993 Aug; 150(8):1255-6. PMID: 8328573.
      View in: PubMed
    71. Killeen TK. Alcoholism and liver transplantation: ethical and nursing implications. Perspect Psychiatr Care. 1993 Jan-Mar; 29(1):7-12. PMID: 8451166.
      View in: PubMed
    Killeen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _